Ivermectin Tablets
Sponsors
Zagazig University, Max Health, Subsero Health, Universidad Nacional de Asunción, Assiut University, Mahidol University
Conditions
COVIDCOVID-19Coronavirus InfectionCovid19ScabiesScabies; Itch
Phase 1
Phase 2
Prophylactic Ivermectin in COVID-19 Contacts
CompletedNCT04422561
Start: 2020-05-31End: 2020-07-27Updated: 2020-08-27
Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients
NCT05155527
Start: 2022-02-10End: 2022-06-30Target: 200Updated: 2022-06-08
A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention
CompletedNCT05305560
Start: 2022-03-25End: 2022-10-13Updated: 2024-12-31
Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)
Active, not recruitingNCT05500326
Start: 2025-06-24End: 2026-06-01Updated: 2026-03-23
Phase 3
Phase 4
An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization
NCT04729140
Start: 2020-12-28End: 2022-03-28Target: 150Updated: 2021-04-01
Ivermectin/ Permethrin for Scabies
CompletedNCT05819983
Start: 2023-01-25End: 2023-03-06Updated: 2023-04-19